Literature DB >> 3903225

Differential quantitation of urinary beta-glucuronidase of human and bacterial origins.

Y C Ho, K J Ho.   

Abstract

A method for the differential quantitation of urinary beta-glucuronidases of human and bacterial origins is presented. The activity of human enzyme at pH 6.5 was 36 per cent of its peak activity at pH 5.0 while the activity of bacterial enzyme at pH 5.0 was 20 per cent of its peak activity at pH 6.5. By simultaneous determination of the activity in a mixture of the enzymes of these two sources at both pH 5.0 and 6.5 and by simple mathematic proportion the individual activity of human and bacterial enzymes could be determined separately. This provides a quick method for differential diagnosis between bacterial and non-bacterial disease of the urinary system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903225     DOI: 10.1016/s0022-5347(17)47700-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Biliary electrolytes and enzymes in patients with and without gallstones.

Authors:  K J Ho
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

2.  Human beta-glucuronidase. Measurement of its activity in gallbladder bile devoid of intrinsic interference.

Authors:  Y C Ho; K J Ho
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

3.  Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase.

Authors:  K J Ho; X Z Lin; S C Yu; J S Chen; C Z Wu
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

4.  Biliary sludge and pigment stone formation in bile duct-ligated guinea pigs.

Authors:  C Y Chen; S C Shiesh; X Z Lin
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

Review 5.  Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

Authors:  J G Hengstler; H Foth; T Gebel; P-J Kramer; W Lilienblum; H Schweinfurth; W Völkel; K-M Wollin; U Gundert-Remy
Journal:  Crit Rev Toxicol       Date:  2011-04       Impact factor: 5.635

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.